Publication at First Faculty of Medicine |
2014
Abstract
Sequential therapy of metastatic renal cell carcinoma belongs to intensely researched issues, and is being dealt with in several randomized and observation studies. So far, it has not been possible to provide unambiguous recommendations regarding the inclusion of individual drugs as their respective predictive markers of efficacy are still missing.